IFN-γ differentially regulates subsets of Gr-1+CD11b+ myeloid cells in chronic inflammation

Molecular Immunology

Volumn 66, Issue 2, 2015, Pages 451-462

  Zhan, Xiaoxia ^a,b   Fang, Yimin ^c   Hu, Shengfeng ^a,b   Wu, Yongjian ^a,b   Yang, Kun ^a,b   Liao, Chunxin ^c   Zhang, Yuanqing ^d   Huang, Xi ^a,b   Wu, Minhao ^a,b,d  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c Guangzhou Chest Hospital   (China)

^d HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

Chronic inflammation; IFN ; Myeloid derived suppressor cells; Neutrophil like myeloid derived inducer cells

Indexed keywords

ARGINASE 1; CD11B ANTIGEN; CD69 ANTIGEN; GAMMA INTERFERON; GR 1 PROTEIN; NITRIC OXIDE; PEPTIDES AND PROTEINS; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; ARG1 PROTEIN, MOUSE; ARGINASE; CHEMOKINE RECEPTOR; GR-1 PROTEIN, MOUSE; LY ANTIGEN; LY6G ANTIGEN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BONE MARROW CELL; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL SUBPOPULATION; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; LYMPHOCYTE PROLIFERATION; MONOCYTE; MOUSE; MYCOBACTERIUM BOVIS BCG; NEUTROPHIL; NONHUMAN; PHENOTYPE; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; SUPPRESSOR CELL; T LYMPHOCYTE ACTIVATION; UPREGULATION; ANIMAL; C57BL MOUSE; CHRONIC DISEASE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEAT; IMMUNOLOGY; INFLAMMATION; LYMPHOCYTE ACTIVATION; MYCOBACTERIUM BOVIS; PATHOLOGY; SIGNAL TRANSDUCTION; SPLEEN; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE;

MYCOBACTERIUM BOVIS BCG;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, LY; ARGINASE; CELL DIFFERENTIATION; CHRONIC DISEASE; FEMALE; GENE EXPRESSION REGULATION; HOT TEMPERATURE; INFLAMMATION; INJECTIONS, SUBCUTANEOUS; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MONOCYTES; MYCOBACTERIUM BOVIS; NEUTROPHILS; REACTIVE OXYGEN SPECIES; RECEPTORS, CHEMOKINE; SIGNAL TRANSDUCTION; SPLEEN; T-LYMPHOCYTES;

EID: 84937974198     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2015.05.011     Document Type: Article

References (46)

1. Abi Abdallah D.S., Egan C.E., Butcher B.A., Denkers E.Y. Mouse neutrophils are professional antigen-presenting cells programmed to instruct Th1 and Th17 T-cell differentiation. Int. Immunol. 2011, 23:317-326.
2. Alves-Filho J.C., Sonego F., Souto F.O., Freitas A., Verri W.A., Auxiliadora-Martins M., Basile-Filho A., McKenzie A.N., Xu D., Cunha F.Q., Liew F.Y. Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat. Med. 2010, 16:708-712.
3. Amulic B., Cazalet C., Hayes G.L., Metzler K.D., Zychlinsky A. Neutrophil function from mechanisms to disease. Annu. Rev. Immunol. 2012, 30:459-489.
4. Bak S.P., Alonso A., Turk M.J., Berwin B. Murine ovarian cancer vascular leukocytes require arginase-1 activity for T cell suppression. Mol. Immunol. 2008, 46:258-268.
5. Beauvillain C., Delneste Y., Scotet M., Peres A., Gascan H., Guermonprez P., Barnaba V., Jeannin P. Neutrophils efficiently cross-prime naive T cells in vivo. Blood 2007, 110:2965-2973.
6. Bryant J., Lerret N.M., Wang J.J., Kang H.K., Tasch J., Zhang Z., Luo X. Preemptive donor apoptotic cell infusions induce IFN-gamma-producing myeloid-derived suppressor cells for cardiac allograft protection. J. Immunol. 2014, 192:6092-6101.
7. Chen G. Immunotherapy of rheumatoid arthritis targeting inflammatory cytokines and autoreactive T cells. Arch. Immunol. Ther. Exp. 2010, 58:27-36.
8. Cripps J.G., Wang J., Maria A., Blumenthal I., Gorham J.D. Type 1T helper cells induce the accumulation of myeloid-derived suppressor cells in the inflamed Tgfb1 knockout mouse liver. Hepatology 2010, 52:1350-1359.
9. Duluc D., Corvaisier M., Blanchard S., Catala L., Descamps P., Gamelin E., Ponsoda S., Delneste Y., Hebbar M., Jeannin P. Interferon-gamma reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages. Int. J. Cancer 2009, 125:367-373.
10. Fridlender Z.G., Sun J., Kim S., Kapoor V., Cheng G., Ling L., Worthen G.S., Albelda S.M. Polarization of tumor-associated neutrophil phenotype by TGF-beta: N1 versus N2 TAN. Cancer Cell 2009, 16:183-194.
11. Gabrilovich D.I., Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 2009, 9:162-174.
12. Greifenberg V., Ribechini E., Rossner S., Lutz M.B. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development. Eur. J. Immunol. 2009, 39:2865-2876.
13. Greten T.F., Manns M.P., Korangy F. Myeloid derived suppressor cells in human diseases. Int. Immunopharmacol. 2011, 11:802-807.
14. Haile L.A., von Wasielewski R., Gamrekelashvili J., Kruger C., Bachmann O., Westendorf A.M., Buer J., Liblau R., Manns M.P., Korangy F., Greten T.F. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. Gastroenterology 2008, 135:871-881. 881. e871-e875.
15. He G., Karin M. NF-KappaB and STAT3 - key players in liver inflammation and cancer. Cell Res. 2011, 21:159-168.
16. Heasman S.J., Giles K.M., Ward C., Rossi A.G., Haslett C., Dransfield I. Glucocorticoid-mediated regulation of granulocyte apoptosis and macrophage phagocytosis of apoptotic cells: implications for the resolution of inflammation. J. Endocrinol. 2003, 178:29-36.
17. Hestdal K., Ruscetti F.W., Ihle J.N., Jacobsen S.E., Dubois C.M., Kopp W.C., Longo D.L., Keller J.R. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J. Immunol. 1991, 147:22-28.
18. + T cells. Gastroenterology 2008, 135:234-243.
19. + immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 2006, 66:1123-1131.
20. Huynh M.L., Fadok V.A., Henson P.M. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J. Clin. Investig. 2002, 109:41-50.
21. Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 2009, 9:239-252.
22. Kanterman J., Sade-Feldman M., Baniyash M. New insights into chronic inflammation-induced immunosuppression. Semin. Cancer Biol. 2012, 22:307-318.
23. Katayama K., Kasahara A., Sasaki Y., Kashiwagi T., Naito M., Masuzawa M., Katoh M., Yoshihara H., Kamada T., Mukuda T., Hijioka T., Hori M., Hayashi N. Immunological response to interferon-gamma priming prior to interferon-alpha treatment in refractory chronic hepatitis C in relation to viral clearance. J. Viral Hepat. 2001, 8:180-185.
24. Lawrence T., Gilroy D.W. Chronic inflammation: a failure of resolution?. Int. J. Exp. Pathol. 2007, 88:85-94.
25. Marciano B.E., Wesley R., De Carlo E.S., Anderson V.L., Barnhart L.A., Darnell D., Malech H.L., Gallin J.I., Holland S.M. Long-term interferon-gamma therapy for patients with chronic granulomatous disease. Clin. Infect. Dis. 2004, 39:692-699.
26. Matsumura T., Ato M., Ikebe T., Ohnishi M., Watanabe H., Kobayashi K. Interferon-gamma-producing immature myeloid cells confer protection against severe invasive group a streptococcus infections. Nat. Commun. 2012, 3:678.
27. Matsushita K., Takenouchi T., Shimada H., Tomonaga T., Hayashi H., Shioya A., Komatsu A., Matsubara H., Ochiai T. Strong HLA-DR antigen expression on cancer cells relates to better prognosis of colorectal cancer patients: possible involvement of c-myc suppression by interferon-gamma in situ. Cancer Sci. 2006, 97:57-63.
28. Mazzoni A., Bronte V., Visintin A., Spitzer J.H., Apolloni E., Serafini P., Zanovello P., Segal D.M. Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. J. Immunol. 2002, 168:689-695.
29. high myeloid derived suppressor cells by modulating the anti-apoptotic molecule Bcl2a1. Eur. J. Immunol. 2014, 44:2457-2467.
30. Milanes-Virelles M.T., Garcia-Garcia I., Santos-Herrera Y., Valdes-Quintana M., Valenzuela-Silva C.M., Jimenez-Madrigal G., Ramos-Gomez T.I., Bello-Rivero I., Fernandez-Olivera N., Sanchez-de la Osa R.B., Rodriguez-Acosta C., Gonzalez-Mendez L., Martinez-Sanchez G., Lopez-Saura P.A. Adjuvant interferon gamma in patients with pulmonary atypical mycobacteriosis: a randomized, double-blind, placebo-controlled study. BMC Infect. Dis. 2008, 8:17.
31. Movahedi K., Guilliams M., Van den Bossche J., Van den Bergh R., Gysemans C., Beschin A., De Baetselier P., Van Ginderachter J.A. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T Cell-suppressive activity. Blood 2008, 111:4233-4244.
32. Muller I., Munder M., Kropf P., Hansch G.M. Polymorphonuclear neutrophils and T lymphocytes strange bedfellows or brothers in arms?. Trends Immunol. 2009, 30:522-530.
33. Ostrand-Rosenberg S., Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 2009, 182:4499-4506.
34. Pan P.Y., Wang G.X., Yin B., Ozao J., Ku T., Divino C.M., Chen S.H. Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function. Blood 2008, 111:219-228.
35. Qin A., Cai W., Pan T., Wu K., Yang Q., Wang N., Liu Y., Yan D., Hu F., Guo P., Chen X., Chen L., Zhang H., Tang X., Zhou J. Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals. J. Virol. 2013, 87:1477-1490.
36. Ryan S.O., Johnson J.L., Cobb B.A. Neutrophils confer T cell resistance to myeloid-derived suppressor cell-mediated suppression to promote chronic inflammation. J. Immunol. 2013, 190:5037-5047.
37. Sade-Feldman M., Kanterman J., Ish-Shalom E., Elnekave M., Horwitz E., Baniyash M. Tumor necrosis factor-alpha blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation. Immunity 2013, 38:541-554.
38. Silva M.T. When two is better than one: macrophages and neutrophils work in concert in innate immunity as complementary and cooperative partners of a myeloid phagocyte system. J. Leukoc. Biol. 2010, 87:93-106.
39. Sinha P., Parker K.H., Horn L., Ostrand-Rosenberg S. Tumor-induced myeloid-derived suppressor cell function is independent of IFN-gamma and IL-4ralpha. Eur. J. Immunol. 2012, 42:2052-2059.
40. Snelgrove R.J., Jackson P.L., Hardison M.T., Noerager B.D., Kinloch A., Gaggar A., Shastry S., Rowe S.M., Shim Y.M., Hussell T., Blalock J.E. A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation. Science 2010, 330:90-94.
41. Tillack K., Breiden P., Martin R., Sospedra M. T lymphocyte priming by neutrophil extracellular traps links innate and adaptive immune responses. J. Immunol. 2012, 188:3150-3159.
42. + T cell responses to bacterial antigens. J. Immunol. 2004, 173:1994-2002.
43. Youn J.I., Collazo M., Shalova I.N., Biswas S.K., Gabrilovich D.I. Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. J. Leukoc. Biol. 2012, 91:167-181.
44. Youn J.I., Nagaraj S., Collazo M., Gabrilovich D.I. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 2008, 181:5791-5802.
45. Young H.A., Bream J.H. IFN-gamma: recent advances in understanding regulation of expression, biological functions, and clinical applications. Curr. Top. Microbiol. Immunol. 2007, 316:97-117.
46. +Ly-6c(Hi) suppressive monocytes in experimental autoimmune encephalomyelitis. J. Immunol. 2007, 179:5228-5237.